Nivolumab with chemotherapy for neoadjuvant treatment of early non-small-cell lung cancer [ID3757]
Proposed [GID-TA10632] Expected publication date: TBC
Search results
1211 results
-
-
Odevixibat (A 4250) for progressive familial intrahepatic cholestasis [ID1570]
Proposed [GID-TA10704] Expected publication date: TBC
-
Sotagliflozin for treating type 2 diabetes [ID1657]
Proposed [GID-TA10665] Expected publication date: TBC
-
Secukinumab for treating enthesitis-related arthritis or juvenile psoriatic arthritis [ID3738]
Proposed [GID-TA10598] Expected publication date: TBC
-
Aducanumab for treating mild cognitive impairment in early Alzheimer's disease [ID3763]
Proposed [GID-TA10739] Expected publication date: TBC
-
Tofacitinib for treating juvenile idiopathic arthritis [ID2718]
Proposed [GID-TA10706] Expected publication date: TBC
-
Mepolizumab for previously treated severe chronic rhinosinusitis with nasal polyps [ID3817]
Proposed [GID-TA10701] Expected publication date: TBC
-
Oleogel-S10 for treating skin wounds associated with epidermolysis bullosa [ID1505]
Proposed [GID-TA10654] Expected publication date: TBC
-
Diroximel fumarate for treating relapsing-remitting multiple sclerosis [ID1673]
Proposed [GID-TA10714] Expected publication date: TBC
-
Enfortumab vedotin for treating locally advanced or metastatic urothelial cancer after 2 therapies [ID3845]
Proposed [GID-TA10727] Expected publication date: TBC
-
LN-145 for treating recurrent, persistent or metastatic cervical cancer [ID3844]
Proposed [GID-TA10728] Expected publication date: TBC
-
Amivantamab for non-small cell lung cancer [ID3836]
Proposed [GID-TA10729] Expected publication date: TBC
-
177Lu-PSMA-617 for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more therapies [ID3840]
Proposed [GID-TA10730] Expected publication date: TBC
-
Vosoritide for treating achondroplasia in children and young people under 18 years [ID3807]
Proposed [GID-TA10700] Expected publication date: TBC
-
Cabotegravir and rilpivirine for treating HIV-1 [ID3766]
Proposed [GID-TA10658] Expected publication date: 20 October 2021
-
Eflornithine with sulindac for treating familial adenomatous polyposis [ID1543]
Proposed [GID-TA10536] Expected publication date: TBC
-
Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment [ID3869]
Proposed [GID-TA10757] Expected publication date: TBC
-
Lurbinectedin with doxorubicin for treating advanced small-cell lung cancer after platinum-based chemotherapy [ID3872]
Proposed [GID-TA10758] Expected publication date: TBC
-
Netarsudil-latanoprost for previously treated open-angle glaucoma or ocular hypertension [ID1363]
Proposed [GID-TA10741] Expected publication date: TBC
-
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs [ID2690]
Proposed [GID-TA10666] Expected publication date: 26 August 2021
-
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus [ID3804]
Proposed [GID-TA10676] Expected publication date: TBC
-
Epicutaneous immunotherapy for treating peanut allergy in children [ID1255]
Proposed [GID-TA10763] Expected publication date: TBC
-
Evinacumab for treating homozygous familial hypercholesterolaemia in people aged 12 and over [ID2704]
Proposed [GID-TA10655] Expected publication date: TBC
-
Abrocitinib for treating moderate to severe atopic dermatitis in people aged 12 and over [ID3768]
Proposed [GID-TA10764] Expected publication date: TBC
-
Liposomal bupivacaine for treating postoperative pain [ID3799]
Proposed [GID-TA10681] Expected publication date: TBC
-
Semaglutide for managing overweight and obesity [ID3850]
Proposed [GID-TA10765] Expected publication date: TBC
-
Burosumab for treating X-linked hypophosphataemia in adults [ID3822]
Proposed [GID-TA10733] Expected publication date: TBC
-
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer(CDF review TA528) [ID1644]
Proposed [GID-TA10782] Expected publication date: 20 October 2021
-
Lumasiran for treating primary hyperoxaluria type 1 [ID3765]
Proposed [GID-TA10660] Expected publication date: TBC
-
Electrotherapy for the treatment of haemorrhoids (IPG525)
Evidence-based recommendations on electrotherapy for treating grade I to III haemorrhoids in adults. This involves using electric current to shrink the
-
Percutaneous transforaminal endoscopic lumbar discectomy for sciatica (IPG556)
Evidence-based recommendations on percutaneous transforaminal endoscopic lumbar discectomy for sciatica in adults. This involves removing part of the damaged
-
Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal (IPG642)
Evidence-based recommendations on Barnett Continent Intestinal Reservoir (modified continent ileostomy) to restore continence after colon and rectum removal
-
Subthalamotomy for Parkinson's disease (IPG65)
Evidence-based recommendations on subthalamotomy for treating Parkinson's disease
-
Endoscopic transluminal pancreatic necrosectomy (IPG567)
Evidence-based recommendations on endoscopic transluminal pancreatic necrosectomy in adults. This involves removing dead tissue from the pancreas
-
Thoracoscopic epicardial radiofrequency ablation for atrial fibrillation (IPG286)
IPG286 1 Guidance 1.1 There is evidence of efficacy for thoracoscopic epicardial radiofrequency ablation for atrial fibrillation
-
Laparoscopic cystectomy (IPG287)
Evidence-based recommendations on laparoscopic cystectomy (keyhole surgery to remove the bladder)
-
Extracorporeal photopheresis for Crohn's disease (IPG288)
Evidence-based recommendations on extracorporeal photopheresis (treated white blood cells) for Crohn's disease
-
Intraocular lens insertion for correction of refractive error, with preservation of the natural lens (IPG289)
Evidence-based recommendations on intraocular (eye) lens insertion for correction of refractive error (short-sightedness), with preservation of the natural lens
-
Extracorporeal shockwave therapy for Peyronie's disease (IPG29)
Evidence-based recommendations on extracorporeal shockwave therapy (ESWT) for treating Peyronie's disease
-
Thoracoscopically assisted mitral valve surgery (IPG245)
Evidence-based recommendations on thoracoscopically assisted mitral valve surgery (keyhole surgery)
-
Hybrid procedure for interim management of hypoplastic left heart syndrome in neonates (IPG246)
Evidence-based recommendations on hybrid procedure for interim management of hypoplastic left heart syndrome (HLHS) in newborn babies
-
Thoracoscopic excision of mediastinal parathyroid tumours (IPG247)
Evidence-based recommendations on thoracoscopic excision (keyhole surgery) of mediastinal parathyroid tumours in the chest
-
Ultrasound-guided catheterisation of the epidural space (IPG249)
Evidence-based recommendations on ultrasound-guided catheterisation of the epidural space to give pain relief or an anaesthetic
-
Laparo-endogastric surgery (IPG25)
Evidence-based recommendations on laparo-endogastric (laparoscopic endoluminal) surgery for treating gastric wall lesions
-
Laser-assisted cerebral vascular anastomosis without temporary arterial occlusion (IPG252)
Evidence-based recommendations on laser-assisted cerebral vascular anastomosis without temporary arterial occlusion
-
Laparoscopic mobilisation of the greater omentum for breast reconstruction (IPG253)
Evidence-based recommendations on laparoscopic mobilisation of the greater omentum (keyhole surgery) for breast reconstruction
-
Endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal masses (IPG254)
Evidence-based recommendations on endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for mediastinal masses
-
Intraoperative nerve monitoring during thyroid surgery (IPG255)
Evidence-based recommendations on intraoperative nerve monitoring during thyroid surgery
-
Brachytherapy as the sole method of adjuvant radiotherapy for breast cancer after local excision (IPG268)
Evidence-based recommendations on brachytherapy as the only type of adjuvant radiotherapy for breast cancer after local excision
-
Laparoscopic gastrectomy for cancer (IPG269)
Evidence-based recommendations on laparoscopic gastrectomy for treating stomach cancer